| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 |
| Sales | 9,297 | 4,483 | 823 | 274 | 238 |
| Sales Growth | +107.38% | +444.71% | +200.37% | +15.13% | +357.15% |
| Net Income | -2,679 | -2,718 | -2,265 | -2,702 | -8,640 |
| Net Income Growth | +1.43% | -20.00% | +16.17% | +68.73% | -725.88% |
Deepverge Plc (DVRG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Deepverge PLC is a scientific research company focused on the production and analysis of bacteria, viruses, and toxins utilizing artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for global cosmetic company clients to remotely detecting water contamination in real-time. The company segments include Life Science, Data AI and Monitoring out of which it generates maximum revenue from Monitoring.
Fiscal Year End Date: 12/31